PITCH - Impacting Hereditary Cancer Testing
Partnering to Impact Testing in the Commonwealth for Hereditary Cancers (PITCH)
1 other identifier
interventional
200
1 country
1
Brief Summary
The goal of this clinical trial is to assess patients' knowledge and attitudes about genetic testing before and after viewing an educational video. The main questions it aims to answer are:
- Did the video change participants' knowledge and attitudes about genetic testing?
- Did participants make an informed choice about pursuing genetic testing? Participants will:
- Complete a baseline survey
- View educational video
- Complete follow-up survey
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable ovarian-cancer
Started May 2026
Shorter than P25 for not_applicable ovarian-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 22, 2025
CompletedFirst Posted
Study publicly available on registry
July 29, 2025
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
March 30, 2026
March 1, 2026
1 month
July 22, 2025
March 24, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Multi-Dimensional Measure of Informed Choice (MMIC) - Cancer Knowledge Scale
The MMIC is a compound assessment tool with three elements which are used together to differentiate an informed choice from a less informed choice. An informed choice is demonstrated by: Achieving =75% (6 of 8 questions) correct responses on the knowledge scale AND Making a decision that is in keeping with one's values related to the outcome (positive vs. negative) A less informed choice is demonstrated by: Achieving \<75% correct responses on the knowledge scale OR Achieving =75% correct responses on the knowledge scale but making a decision that is inconsistent with one's values (e.g., a patient values the information that may be obtained but chose not to undergo testing OR a patient does not value the information and chose to undergo testing)
Baseline and post intervention (approximately 30 minutes)
Secondary Outcomes (1)
Number of participants completing genetic testing
90 days
Study Arms (1)
Educational Video
EXPERIMENTALParticipants will complete a survey before and after viewing an educational video
Interventions
patient education video about genetic testing for hereditary cancers
Eligibility Criteria
You may qualify if:
- diagnosed with a cancer that can be associated with hereditary forms of cancer
You may not qualify if:
- previously undergone multi-gene panel testing for hereditary cancers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rachel Millerlead
Study Sites (1)
University of Kentucky
Lexington, Kentucky, 40506, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rachel Miller, MD
University of Kentucky
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 22, 2025
First Posted
July 29, 2025
Study Start
May 1, 2026
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
March 30, 2026
Record last verified: 2026-03